Overview
Aromasin contains Exemestane 25 mg, a non-steroidal aromatase inhibitor used in the treatment of hormone-receptor positive breast cancer in postmenopausal women. Exemestane works by blocking the enzyme aromatase, which helps reduce estrogen production, limiting the hormone's ability to fuel cancer cell growth. Aromasin is often prescribed as part of a post-surgical hormonal therapy regimen for early-stage breast cancer or to treat advanced cases.





